Last reviewed · How we verify
NCT06591780
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
NA trial testing Clinical Evaluation in Diabetic Peripheral Neuropathy in 25 participants. Currently enrolling.
1 June 2027
Quick facts
| Lead sponsor | Florida Institute for Human and Machine Cognition |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 25 |
| Start date | 20 October 2025 |
| Primary completion | 1 June 2027 |
| Estimated completion | 1 June 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Clinical Evaluation — full drug profile →
- Plantar Pressure Biofeedback Gait Training
- Propulsion Biofeedback Gait Training
Conditions studied
- Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Florida Institute for Human and Machine Cognition
Who can join
Adults 45 to 90, any sex, with Diabetic Peripheral Neuropathy or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN). The primary goals are to evaluate: * Biomechanical mechanisms contributing to abnormal plantar pressure and propulsion during gait in individuals with DPN * Biofeedback-induced changes in plantar pressure, propulsion, and biomechanics during gait in individuals with DPN The participants will be required to complete * Questionnaires * Clinical examination * 3-Dimensional gait analysis on an instrumented treadmill * Visual and auditory biofeedback on the participant's propulsion and plantar pressure metrics provided by a projector screen during walking
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06591780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Clinical Evaluation
Trials testing the same drug.
- NCT05702645 — A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia · recruiting
- NCT05766332 — Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant · completed
- NCT05036330 — ProvoxLife Adoption Trends for Heat-Moisture Exchanger · active not recruiting
- NCT04785534 — Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis · NA · active not recruiting
- NCT03849482 — Multiparametric Magnetic Resonance Imaging Versus Fine Needle Aspiration Cytology for Parotid Gland Neoplasms · unknown
Other recruiting trials for Diabetic Peripheral Neuropathy
Currently open trials in the same condition.
- NCT07380880 — Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neurop · NA · recruiting
- NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
- NCT07085130 — The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy · NA · active not recruiting
- NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting
- NCT06797869 — A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful · Phase 2 · active not recruiting
Other Florida Institute for Human and Machine Cognition trials
Trials by the same sponsor.
- NCT06507189 — Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX) · NA · recruiting
- NCT07065864 — Ketone Esters for Optimization of Operator Performance in Hypoxia · NA · completed
- NCT04738838 — Oxytocin on Cold Water Task Performance and Recovery · Phase 2 · completed
- NCT04732247 — Oxytocin for Oxidative Stress and Inflammation · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06591780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Florida Institute for Human and Machine Cognition
- Last refreshed: 11 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06591780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing